Cross Reactivity of Positive Human Plasma Samples for DDAbs
| Sample No. . | A2-L . | A1-L . | A3 . | B . |
|---|---|---|---|---|
| 7 | + | + | + | + |
| 46 | + | + | + | + |
| 69 | + | − | + | + |
| 116 | + | − | − | − |
| 138 | − | + | − | − |
| 145 | − | + | − | − |
| 258 | − | + | − | − |
| 260 | − | + | − | − |
| 366 | + | − | − | − |
| 407 | + | − | − | − |
| 460 | + | + | − | − |
| 471 | + | − | + | − |
| 883 | + | − | + | − |
| 931 | + | − | − | − |
| 951 | − | − | + | − |
| 952 | − | − | + | − |
| 1051 | + | + | + | + |
| 1084 | − | − | − | + |
| Sample No. . | A2-L . | A1-L . | A3 . | B . |
|---|---|---|---|---|
| 7 | + | + | + | + |
| 46 | + | + | + | + |
| 69 | + | − | + | + |
| 116 | + | − | − | − |
| 138 | − | + | − | − |
| 145 | − | + | − | − |
| 258 | − | + | − | − |
| 260 | − | + | − | − |
| 366 | + | − | − | − |
| 407 | + | − | − | − |
| 460 | + | + | − | − |
| 471 | + | − | + | − |
| 883 | + | − | + | − |
| 931 | + | − | − | − |
| 951 | − | − | + | − |
| 952 | − | − | + | − |
| 1051 | + | + | + | + |
| 1084 | − | − | − | + |
Screening of 1,032 human plasma samples for DDAbs using flow cytometric assay (for details, see Materials and Methods). The samples shown above were positive to at least one of the listed antagonists.